Alx Oncology Holdings's long-term debt is $9.7M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), ALXO shows a long-term debt of $9.7M. That compares with $11M in the prior-year period — down 12.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ALXO's long-term debt is now $9.7M (was $11M) — a 12.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Alx Oncology Holdings is outperforming or lagging.
Tracking ALXO's long-term debt over time shows whether Alx Oncology Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $9.7M That compares with $11M in the prior-year period — down 12.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has Alx Oncology Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $9.7M) with ownership activity and broader fundamentals.
Alx Oncology Holdings's long-term debt is $9.7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.